LENEXA, Kan., April 29, 2005 (PRIMEZONE) -- Mediware Information Systems, Inc. (Nasdaq:MEDW) will release financial results for its 2005 fiscal year third quarter ended March 31, 2005 on Wednesday, May 4, 2005. A teleconference call to discuss the results is scheduled for the same day at 10:30am EDT.
The company said revenue for the third quarter reached record levels. Late in the quarter the Medication Management Division achieved referenceability on its MediMAR product. Good progress is being made in the migration of blood bank division customers to the company's new HCLL(TM) Transfusion system, the company reported. The company also said the quarter and near term results will continue to be affected by the transition costs along with costs associated with Sarbanes-Oxley compliance. The company remains pleased with customer interest in its new products.
To participate in the teleconference, please call 877.210.6102 (International 785.832.2422) five minutes before the scheduled start and provide the operator with Access Code: Mediware Q3. A replay of the call will be available for 10 days at 888.567.0680 (International 402.530.0422).
About Mediware
Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include HCLL(TM) Transfusion, LifeTrak(R), IIE(TM) (Instrument Interface Engine), Hemocare(R), LifeLine(TM) (Blood Bank), WORx(R), Pharmakon(R), and Digimedics(TM) (Pharmacy), Surgiware(TM) and Perioperative Solutions(TM) (Operating Room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.
Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.